Skip to content
Skip to main content
header search
ahihi OpenLearn
OpenLearn
Menu
sticky search

About this free course

Become an OU student

Download this course

Share this free course

Course content Course content
The MMR vaccine: public health, private fears
The MMR vaccine: public health, private fears

Start this free course now. Just create an account and sign in. Enrol and complete the course for a free statement of participation or digital badge if available.

More free courses

11.7 References for Reading 4

Horton, R. (2004) ‘The lessons of MMR’, The Lancet, 363, 6 March 2004, pp 747–749 Elsevier. Copyright © 2004 Elsevier.

  1. Murch, SH, Anthony, A, Cassen, DH, et al. ‘Retraction of an interpretation’. Lancet 2004; 363:750.

  2. Wakefield, AJ, Murch, SH, Anthony, A, et al. ‘Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children’. Lancet 1998; 351:637–41.

  3. Horton, R. ‘A statement by the editors of The Lancet’. Lancet 2004; 363: 820–21.

  4. Kanner, L. ‘Autistic disturbances of affective contact’. Nervous Child 1943; 2: 217–50.

  5. Volkmar, FR, Pauls, D. ‘Autism’. Lancet 2003;362:1133–41.

  6. Goode, E. ‘Autism cases up; cause is unclear’. New York Times Jan 26, 2004: A1.

  7. Volkmar, FR, Cohen, DJ. ‘Disintegrative disorder or “late onset” autism’. J Child Psychol Psychiatry 1989; 30:717–24.

  8. MRC review of autism research: epidemiology and causes. London: MRC, 2001.

  9. Farthing, M, Horton, R, Smith, R. ‘UK's failure to act on research misconduct’. Lancet 2000; 356:2030.

  10. Jefferson, T, Price, D, Demicheli, V, et al. ‘Unintended events following immunisation with MMR: a systematic review’. Vaccine 2003; 21:3954–60.

  11. Jefferson, T. ‘Informed choice and balance are victims of the MMR-autism saga’. Lancet Infect Dis 2004; 4: 135–36.

  12. Editorial. ‘This orchestrated campaign must not be allowed to stifle real debate on MMR’. The Independent Feb 24, 2004: 16.

  13. Torrente, F, Anthony, A, Heuschkel, RB et al. ‘Focal enhanced gastritis in regressive autism with features distinct from Crohn's and Helicobacterpylori gastritis’. Am J Gastroenterol (in press).

  14. DeFelice, ML, Ruchelli, ED, Markowitz, JE, et al. ‘Intestinal cytokines in children with pervasive developmental disorders’. Am J Gastroenterol 2003; 98: 1777–82.

  15. Shapin, S. A social history of truth. Chicago: University of Chicago Press, 1995.

  16. Roberts, KA, Dixon-Woods, M, Fitzpatrick, R, Abrams, KR, Jones, DR. ‘Factors affecting uptake of childhood immunisation: a Bayesian synthesis of qualitative and quantitative evidence’. Lancet 2002; 360: 1596–99.

  17. Davidoff, F, DeAngelis, CD, Drazen, JM, et al. ‘Sponsorship, authorship, and accountability’. Lancet 2001;358: 854–56.

  18. James, A, Horton, R. ‘The Lancet policy on conflicts of interest’. Lancet 2003;361: 8–9.

  19. James, A, Horton, R, Collingridge, D, McConnell, J, Butcher, J. ‘The Lancet's policy on conflicts of interest-2004’. Lancet 2004; 363:2–3.

  20. Editorial. ‘Dissent must be aired’. Times Higher Educational Supplement Feb 27, 2004: 14.

  21. McBride, WG. ‘Thalidomide and congenital abnormalities’. Lancet 1961; ii: 1358.

  22. Calman, KC. ‘Communication of risk: choice, consent, and trust’. Lancet 2002;360:166–68.

  23. Anonymous. ‘MMR vaccine-how effective and how safe?’ Drug Ther Bull 2003; 41: April, 1–6.